Ultrasound-assisted intrathecal injection of nusinersen in a patient with severe vertebral deformity: a case report
Abstract Background Spinal muscular atrophy (SMA) is a mostly autosomal recessive genetic disease characterized by progressive muscle weakness from anterior horn degeneration. Nusinersen has recently been approved as a disease-modifying drug for SMA that needs to be administered intrathecally. Its i...
| Автори: | , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
SpringerOpen
2020-08-01
|
| Серія: | JA Clinical Reports |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s40981-020-00367-y |